发明名称 |
NOVEL COMPOUNDS |
摘要 |
The present invention relates to new compounds of formula (I) wherein R<1>, R<2>, R<3>, R<4>, R<5> and A are defined as in formula (I), a process for their preparation and new intermediate prepared therein, pharmaceutical compositions containing said therapeutically active compounds and to the use of said active compounds in therapy, especially in the treatment of c-Jun N-terminal kinase (JNK) mediated conditions in mammals, particularly Alzheimer's Disease. |
申请公布号 |
WO03051277(A2) |
申请公布日期 |
2003.06.26 |
申请号 |
WO2002SE02374 |
申请日期 |
2002.12.18 |
申请人 |
ASTRAZENECA AB;KING, SARAH;TEAGUE, SIMON;XUE, YAFENG;SWAHN, BRITT-MARIE |
发明人 |
KING, SARAH;TEAGUE, SIMON;XUE, YAFENG;SWAHN, BRITT-MARIE |
分类号 |
A61K31/4184;A61K31/454;A61K31/4709;A61K31/496;A61P1/02;A61P1/04;A61P1/16;A61P1/18;A61P3/10;A61P5/14;A61P7/00;A61P7/02;A61P7/04;A61P7/06;A61P7/10;A61P9/10;A61P11/00;A61P11/06;A61P13/12;A61P17/00;A61P17/02;A61P17/06;A61P19/00;A61P19/02;A61P19/10;A61P21/00;A61P21/04;A61P25/00;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/28;A61P27/02;A61P29/00;A61P29/02;A61P31/04;A61P31/12;A61P31/14;A61P31/18;A61P31/20;A61P35/00;A61P35/02;A61P35/04;A61P37/02;A61P37/04;A61P37/06;A61P37/08;A61P43/00;C07D235/26;C07D235/28;C07D401/12;C07D401/14;C07D403/12;C07D403/14;C07D405/14 |
主分类号 |
A61K31/4184 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|